Aarti Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 27-06-2024
- Paid Up Capital ₹ 1.40 Cr
as on 27-06-2024
- Company Age 30 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -11.42%
(FY 2022)
- Profit -36.52%
(FY 2022)
- Ebitda -48.47%
(FY 2022)
- Net Worth 1.95%
(FY 2022)
- Total Assets 1.52%
(FY 2022)
About Aarti Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.40 Cr, as per Ministry of Corporate Affairs (MCA) records.
Paresh Vora, Mahesh Vikam, and Kalpesh Mehta serve as directors at the Company.
- CIN/LLPIN
U01110MH1994PTC082031
- Company No.
082031
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Oct 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aarti Bio-Tech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Vora  | Director | 10-Nov-2009 | Current |
| Mahesh Vikam | Director | 23-Mar-2022 | Current |
| Kalpesh Mehta | Director | 10-Mar-2016 | Current |
Financial Performance and Corporate Structure Insights of Aarti Bio-Tech.
Aarti Bio-Tech Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.42% decrease. The company also saw a substantial fall in profitability, with a 36.52% decrease in profit. The company's net worth moved up by a moderate rise of 1.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aarti Bio-Tech?
In 2021, Aarti Bio-Tech had a promoter holding of 18.45% and a public holding of 81.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dilesh Roadlines Private LimitedActive 32 years 9 monthsParesh Vora and Kalpesh Mehta are mutual person
- Drl Cargo Carriers Private LimitedActive 14 years 4 months
Paresh Vora and Kalpesh Mehta are mutual person
- Dilesh Logistics (India) Private LimitedActive 14 years 3 months
Paresh Vora and Kalpesh Mehta are mutual person
- Alchemie Speciality Chemicals Private LimitedActive 8 years 4 months
Mahesh Vikam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aarti Bio-Tech?
Unlock and access historical data on people associated with Aarti Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aarti Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aarti Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
